financetom
Business
financetom
/
Business
/
Market Chatter: Allstate's National General Faces Lawsuit Over Failure to Report Data Breach
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Allstate's National General Faces Lawsuit Over Failure to Report Data Breach
Mar 10, 2025 8:57 AM

11:42 AM EDT, 03/10/2025 (MT Newswires) -- Allstate's ( ALL ) National General unit is being sued by New York state for failing to report a data breach that exposed license numbers and for lacking adequate security measures to protect drivers' private information, Reuters reported Monday.

The lawsuit was filed in a Manhattan state court by New York Attorney General Letitia James, according to the report.

Data breaches at National General in 2020 and 2021 exposed license numbers of more than 199,000 people, including 165,000 New Yorkers, the report added, citing James.

Allstate ( ALL ) and National General did not immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 201.78, Change: +2.05, Percent Change: +1.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AMC Entertainment Stock Is Rising Monday: What's Going On?
AMC Entertainment Stock Is Rising Monday: What's Going On?
Jul 29, 2024
AMC Entertainment Holdings Inc ( AMC ) shares are on watch higher. The company announced it posted its highest weekend attendance and admissions revenue of 2024. What Happened: AMC announced that it set new 2024 records for weekend attendance and admissions revenue at its U.S. AMC theater locations this past Thursday through Sunday. AMC also set new 2024 records at its...
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
Jul 29, 2024
vTv Therapeutics Inc. ( VTVT ) stock is trading lower on Monday. The FDA has placed a clinical hold on the cadisegliatin clinical program, which includes the ongoing CATT1 Phase 3 trial in type 1 diabetes.  Cadisegliatin is an oral, liver-selective, glucokinase activator. The company says the drug candidate has been well-tolerated in over 500 subjects to date with up to six...
Enlight Renewable Energy Finalizes $827 Million Financing for Atrisco Solar and Storage Project
Enlight Renewable Energy Finalizes $827 Million Financing for Atrisco Solar and Storage Project
Jul 29, 2024
11:25 AM EDT, 07/29/2024 (MT Newswires) -- Enlight Renewable Energy ( ENLT ) announced Monday the financial close for the energy storage portion of its Atrisco Solar and Energy Storage project near Albuquerque, New Mexico. The $827 million project, combining 364 MW of solar capacity with 1.2 GWh of battery storage, will be financed by term debt of $290 million...
Acumen Pharmaceuticals Doses First Person in Phase 1 Study of Sabirnetug for Alzheimer's Disease
Acumen Pharmaceuticals Doses First Person in Phase 1 Study of Sabirnetug for Alzheimer's Disease
Jul 29, 2024
11:18 AM EDT, 07/29/2024 (MT Newswires) -- Acumen Pharmaceuticals ( ABOS ) said Monday it has dosed the first person with a subcutaneous formulation of sabirnetug in a phase 1 study of the drug to potentially treat early Alzheimer's disease. The trial will compare the pharmacokinetic between subcutaneous and intravenous administrations of the candidate drug in healthy people, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved